Enduring Material

Psound Bytes: Measuring PsA Symptoms in Clinical Trials
View Activity Info
Enter Basic User Info
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Thursday, June 4, 2020 - Friday, June 3, 2022
National Psoriasis Foundation
Virtual Conference Room
Psound Bytes CME Podcast
National Psoriasis Foundation
Objectives
  • Understand the pathology of psoriatic disease, its manifestations and related comorbidities, indicating why it’s important to treat the disease to target.
  • Develop strategies for improving psoriatic disease health outcomes through management and treatment options which includes patient lifestyle changes to current and emerging pharmacologic therapies.
  • Select appropriate therapies for moderate to severe psoriatic disease based on current evidence for efficacy, safety and adherence, particularly with regard to comorbidities.
Presentations and Speakers
Psound Bytes: Measuring PsA Symptoms in Clinical Trials
  • Elaine Husni, MD - Cleveland Clinic
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Could inclusion of measuring psoriatic arthritis symptoms in psoriasis clinical trials be a step towards reducing the gap in diagnosis of PsA? That's a question asked of renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Diseases and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Hear this discussion of the JAAD article "Measuring Psoriatic Arthritis Symptoms: A Core Domain in Psoriasis Clinical Trials".
Disclosure Statements
Andi Agnew, NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Speakers:
Elaine Husni, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:
  • Abbvie, Amgen, BMS, Lilly, Novartis, Janssen, UCB - Advisory Committee Member
  • PASE Questionnaire - Receives royalties
Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
0 %
6/4/2020
Continue to Enduring Material